Horizon Europe Call: Advancing the European Bio-based Innovation Enabled by Biotechnology and Biomanufacturing Concepts (HORIZON-CL6-2026-01-CIRCBIO-07)

The European Commission has launched a Horizon Europe funding opportunity aimed at accelerating bio-based innovation through advanced biotechnology and biomanufacturing concepts. The call seeks to support research and innovation activities that strengthen Europe's bioeconomy while contributing to

FORTHCOMING | Horizon Europe Health Call 2027: Development of Innovative Antimicrobials Against Drug-Resistant Pathogens

The European Commission has announced a forthcoming Horizon Europe Cluster 1: Health funding opportunity aimed at accelerating the development of innovative antimicrobial therapies to combat antimicrobial-resistant (AMR) bacterial and fungal pathogens.

Antimicrobial resistance remains one of the most

Development of Monoclonal Antibodies to Prevent and Treat Infections from Filo-, Nairo-, Phenui-, Picorna- and Toga Viruses

Programme: Horizon Europe (HORIZON) – Cluster 1: Health
Topic Code: HORIZON-HLTH-2027-01-DISEASE-07
Type of Action: Research and Innovation Action (RIA)
Funding Type: Horizon Europe Grant Funding
Opening Date: 10 February 2027
Closing Date: 13 April 2027 (17:00 Brussels Time)

The European Commission

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges – Pilot introduce a two‑stage, ARPA‑inspired support model to speed up high‑risk, demand‑driven deep tech innovation from solution concept to real‑world validation with users.​

Opportunity overview

The EIC Advanced Innovation Challenges (AIC) – Pilot aim to close the

EIC Transition

EIC Transition is a Research and Innovation Action that funds the maturation of promising EU‑funded research results from lab‑scale proof of concept (completed TRL 3–4) towards TRL 5–6 and market‑ready business models.​

Opportunity overview

EIC Transition supports projects that build on results from